Your search for tofacitinib returned 109 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for tofacitinib returned 109 results

Sort Results:

Relevant Recent
Drug Monograph Updates

August 2014 Recap of Drug Updates

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of August. The chart below provides highlights of key monograph updates made this month (not an inclusive list).
News

Xeljanz Label Gains Radiographic Data Addition

Pfizer announced that the FDA has approved a sNDA to update the current label of Xeljanz (tofacitinib citrate) tablets to include radiographic data from two Phase 3 studies, ORAL Scan and ORAL Start.
News

FDA Approves Additional Labeling for Xeljanz

Pfizer announced that the FDA has approved the supplemental New Drug Application (sNDA) for Xeljanz (tofacitinib citrate) to include additional patient-reported outcomes data in the label.
Features

May 2013 New Drug CME/CEU Review

This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.
News

Xeljanz Approved for Rheumatoid Arthritis

Pfizer announced that the FDA has approved Xeljanz (tofacitinib citrate) tablets for the treatment of adults with moderately-to-severely active rheumatoid arthritis (RA) who have had inadequate response or intolerance to methotrexate.
Patient Fact Sheets

Rheumatoid Arthritis Patient Information Fact Sheet

This patient information fact sheet provides information on the definition, symptoms, causes, diagnostic tests, treatments and self-help measures for rheumatoid arthritis.